ICU Medical Company Top Insiders
| ICUI Stock | USD 138.53 4.14 2.90% |
ICU Medical employs about 15 K people. The company is managed by 8 executives with a total tenure of roughly 28 years, averaging almost 3.0 years of service per executive, having 1875.0 employees per reported executive. Assessment of ICU Medical's management performance can provide insight into the firm performance.
| Vivek Jain Chairman Chairman and CEO |
| Virginia Sanzone President Vice President General Counsel, Secretary |
ICU Medical Management Team Effectiveness
The company has return on total asset (ROA) of 0.0192 % which means that it generated a profit of $0.0192 on every $100 spent on assets. This is way below average. ICU Medical's management efficiency ratios could be used to measure how well ICU Medical manages its routine affairs as well as how well it operates its assets and liabilities.The majority of ICU Medical outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in ICU Medical to benefit from reduced commissions. Therefore, third-party entities are subject to a different set of regulations than regular investors in ICU Medical. Please pay attention to any change in the institutional holdings of ICU Medical as this could imply that something significant has changed or is about to change at the company.
Some institutional investors establish a significant position in stocks such as ICU Medical in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of ICU Medical, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
ICU Medical Workforce Comparison
ICU Medical is currently regarded as number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 45,720. ICU Medical totals roughly 15,000 in number of employees claiming about 33% of equities under Health Care industry.
ICU Medical Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ICU Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on ICU Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, ICU Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ICU Medical Notable Stakeholders
An ICU Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as ICU Medical often face trade-offs trying to please all of them. ICU Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting ICU Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Vivek Jain | Chairman and CEO | Profile | |
| Virginia Sanzone | Vice President General Counsel, Secretary | Profile | |
| Daniel Woolson | President | Profile | |
| Clay Fradd | Corporate Resources | Profile | |
| Christian Voigtlander | Chief Officer | Profile | |
| Brian Bonnell | CFO Treasurer | Profile | |
| Ben Sousa | Chief Officer | Profile | |
| Olivia Barrall | Vice Resources | Profile |
About ICU Medical Management Performance
The success or failure of an entity such as ICU Medical often depends on how effective the management is. ICU Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of ICU management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the ICU management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. ICU Medical, Inc. was founded in 1984 and is headquartered in San Clemente, California. I C operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 15300 people.
ICU Medical Workforce Analysis
Traditionally, organizations such as ICU Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare ICU Medical within its industry.ICU Medical Manpower Efficiency
Return on ICU Medical Manpower
| Revenue Per Employee | 158.8K | |
| Revenue Per Executive | 297.8M | |
| Net Loss Per Employee | 7.8K | |
| Net Loss Per Executive | 14.7M | |
| Working Capital Per Employee | 59.1K | |
| Working Capital Per Executive | 110.7M |
Complementary Tools for ICU Stock analysis
When running ICU Medical's price analysis, check to measure ICU Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Medical is operating at the current time. Most of ICU Medical's value examination focuses on studying past and present price action to predict the probability of ICU Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Medical's price. Additionally, you may evaluate how the addition of ICU Medical to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Stocks Directory Find actively traded stocks across global markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |